Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants

Trial Identifier:	D5985C00006
Sponsor:	AstraZeneca
Start Date:	June 2023
Primary Completion Date:	July 2024
Study Completion Date:	July 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Glasgow, GB, G4 0SF
US, KS	Kansas City, KS, US, 66160
US, MD	Baltimore, MD, US, 21287
US, NC	Chapel Hill, NC, US, 27599
US, PA	Pittsburgh, PA, US, 15213

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.